Key clinical point: Adult atopic dermatitis patients who use potent or superpotent topical corticosteroids face significantly increased risks of osteoporosis and major osteoporotic fractures.
Major finding: Danish adults with atopic dermatitis who never used systemic corticosteroids had risks of osteoporosis and major osteoporotic fractures that were 82% and 14% greater than in matched controls.
Study details: This was a retrospective case-control study of 10,636 Danish adults with atopic dermatitis and 87,989 matched controls.
Disclosures: This Danish national registry study was conducted using government research funds. Dr. Thyssen reported serving as an advisor to and/or recipient of research grants from AbbVie, Pfizer, Leo Pharma, Eli Lilly, Regeneron, Sanofi Genzyme, and Union Therapeutics.